These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 38670393)

  • 1. Elucidating the mechanism of action of Isobavachalcone induced autophagy and apoptosis in non-small cell lung cancer by network pharmacology and experimental validation methods.
    Wang L; Wang Z; Ni Y; Wang X; Zhang T; Hu M; Lian C; Wang X; Zhang J
    Gene; 2024 Aug; 918():148474. PubMed ID: 38670393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mechanism of n-butanol fraction of Wenxia Formula combining with gefitinib in treating non-small cell lung cancer based on network pharmacology and in vitro experiment].
    Chen RJ; Bi QY; Shi JM; Zhong J; Han JT; Ji XM
    Zhongguo Zhong Yao Za Zhi; 2024 Jan; 49(2):471-486. PubMed ID: 38403323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of the mechanism of Isobavachalcone in treating rheumatoid arthritis through a combination strategy of network pharmacology and experimental verification.
    Wang S; Du Q; Sun J; Geng S; Zhang Y
    J Ethnopharmacol; 2022 Aug; 294():115342. PubMed ID: 35525528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Research on the Regulatory Mechanism of Ginseng on the Tumor Microenvironment of Colorectal Cancer based on Network Pharmacology and Bioinformatics Validation.
    Wang T; Zhang W; Fang C; Wang N; Zhuang Y; Gao S
    Curr Comput Aided Drug Des; 2024; 20(5):486-500. PubMed ID: 37287284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanistic prediction and validation of Brevilin A Therapeutic effects in Lung Cancer.
    Wang R; Gao C; Yu M; Song J; Feng Z; Wang R; Pan H; Liu H; Li W; Fan X
    BMC Complement Med Ther; 2024 Jun; 24(1):214. PubMed ID: 38840248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mechanism of Bai He Gu Jin Tang against non-small cell lung cancer revealed by network pharmacology and molecular docking.
    Xie RF; Song ZY; Xu-Shao LY; Huang JG; Zhao T; Yang Z
    Medicine (Baltimore); 2022 Dec; 101(52):e32555. PubMed ID: 36596057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding apoptotic induction by Sargentodoxa cuneata-Patrinia villosa herb pair via PI3K/AKT/mTOR signalling in colorectal cancer cells using network pharmacology and cellular studies.
    Mu BX; Li Y; Ye N; Liu S; Zou X; Qian J; Wu C; Zhuang Y; Chen M; Zhou JY
    J Ethnopharmacol; 2024 Jan; 319(Pt 3):117342. PubMed ID: 37879505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Blaps rynchopetera affects proliferation, migration, and invasion of non-small cell lung cancer: a study based on network pharmacology and in vivo and in vitro experiments].
    Li XY; Ma K; Yan JN; You FC; Ma L
    Zhongguo Zhong Yao Za Zhi; 2023 Jul; 48(13):3576-3588. PubMed ID: 37474991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification.
    Wang Y; Chu F; Lin J; Li Y; Johnson N; Zhang J; Gai C; Su Z; Cheng H; Wang L; Ding X
    J Ethnopharmacol; 2021 Oct; 279():114399. PubMed ID: 34246740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition effect of oxyepiberberine isolated from Coptis chinensis franch. On non-small cell lung cancer based on a network pharmacology approach and experimental validation.
    Zhang Y; Yao Y; Fu Y; Yuan Z; Wu X; Wang T; Hong Z; Yang Y; Wu H
    J Ethnopharmacol; 2021 Oct; 278():114267. PubMed ID: 34087401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Network module analysis and molecular docking-based study on the mechanism of astragali radix against non-small cell lung cancer.
    Xiao W; Xu Y; Baak JP; Dai J; Jing L; Zhu H; Gan Y; Zheng S
    BMC Complement Med Ther; 2023 Sep; 23(1):345. PubMed ID: 37770919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrating network pharmacology and experimental verification to investigate the pharmacological mechanisms of Buzhong Yiqi decoction in the treatment of non-small cell lung cancer.
    Zeng P; Wang F; Zhang J; Ur Rashid H; Li X; Zhang P; Luo Y; Wu X
    Chem Biol Drug Des; 2024 Jan; 103(1):e14414. PubMed ID: 38230796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Network pharmacology analysis, molecular docking integrated experimental verification reveal β-sitosterol as the active anti-NSCLC ingredient of Polygonatum cyrtonema Hua by suppression of PI3K/Akt/HIF-1α signaling pathway.
    Cao W; Yuan F; Liu T; Yin R
    J Ethnopharmacol; 2024 Jun; 328():117900. PubMed ID: 38432577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Network pharmacology and molecular docking reveal the mechanism of Scopoletin against non-small cell lung cancer.
    Yuan C; Wang MH; Wang F; Chen PY; Ke XG; Yu B; Yang YF; You PT; Wu HZ
    Life Sci; 2021 Apr; 270():119105. PubMed ID: 33497736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway.
    Lin F; Zhang G; Yang X; Wang M; Wang R; Wan M; Wang J; Wu B; Yan T; Jia Y
    J Ethnopharmacol; 2023 Mar; 303():115933. PubMed ID: 36403742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrating Network Pharmacology and Experimental Verification to Explore the Pharmacological Mechanisms of Aloin Against Gastric Cancer.
    Gao J; Yang S; Xie G; Pan J; Zhu F
    Drug Des Devel Ther; 2022; 16():1947-1961. PubMed ID: 35757520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-targeted effects of D-carvone against Non-Small Cell Lung Cancer (NSCLC): A network pharmacology-based study.
    Irshad R; Batool F; Raj N; Karim S; Alkreathy HM; Manzoor N; Husain M
    Toxicol Appl Pharmacol; 2024 Jun; 487():116978. PubMed ID: 38795847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential mechanism of Chai Gui Zexie Decoction for NSCLC treatment assessed using network pharmacology, bioinformatics, and molecular docking: An observational study.
    Lin M; Zhao A; Chen B
    Medicine (Baltimore); 2024 May; 103(20):e38204. PubMed ID: 38758858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isobavachalcone isolated from
    Li Y; Qin X; Li P; Zhang H; Lin T; Miao Z; Ma S
    Drug Des Devel Ther; 2019; 13():1449-1460. PubMed ID: 31118579
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of "Hedyotis Diffusae Herba-Smilacis Glabrae Rhizoma" in treatment of lung adenocarcinoma based on network pharmacology].
    Li JL; Hou W
    Zhongguo Zhong Yao Za Zhi; 2021 Dec; 46(23):6261-6270. PubMed ID: 34951253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.